目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table 0A : Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, Through 2024
Figure 0A : Global Market for Organ and Tissue Transplantation and Alternatives, by Product & Devices, 2018-2024
Figure 0B : Global Market Shares of Organ and Tissue Transplantation and Alternatives, by Alternative Technologies, 2019
Figure 0C : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Tissue Products, 2019
Figure 0D : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Immunosuppressants, 2019
Figure 0E : Global Market Shares for Organ and Tissue Transplantation and Alternatives, by Solid Organ Preservation Solutions, 2019
Table 0B : Global Market for Organ and Tissue Transplantation and Alternatives, by Region, Through 2024
Chapter- 3: Market and Technology Background
Organ and Tissue Transplantation and Alternatives
Cost of Care
Solid Organ Preservation
Immunosuppression
Organ Transplantation Alternatives
Trends in Organ and Tissue Transplantation Techniques and Their Alternatives
Chapter- 4: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Chapter- 5: Market Breakdown by Product & Devices
Global Market for Organ and Tissue Transplantation and Alternatives
Alternative Technologies
Tissue Products
Immunosuppressants
Solid Organ Preservation Solutions
Tissue Typing
Chapter- 6: Market Breakdown by Region
Global Market for Organ and Tissue Transplantation and Alternatives by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 7: Impact of COVID-19
Introduction
Chapter- 8: Overview of Donation Process
Introduction
Chapter- 9: Regulations & Reimbursement
Regulations in the U.S.
U.S. Federal Regulation of Human Tissue
History of Regulation in the U.S.
Regulations Outside the U.S.
Reimbursement in the U.S.
Organ Acquisition Costs
Reimbursement for Hospital Costs
Reimbursement for Physician Services
Reimbursement for Immunosuppressants in the U.S.
Reimbursement Outside the U.S.
Treatment in EU Countries
Chapter- 10: Competitive Landscape
Global Company Ranking Analysis
Mergers and Acquisitions
Agreements, Launches, Collaborations, and Partnerships
Chapter- 11: Company Profiles
ABIOMED INC.
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BAYER AG
BRISTOL-MYERS SQUIBB
CAREDX INC.
F. HOFFMANN-LA ROCHE LTD.
JOHNSON & JOHNSON
MYLAN N.V.
NOVARTIS AG
PFIZER INC.
TRANSMEDICS INC.
VERTEX PHARMACEUTICALS INC.
XVIVO PERFUSION
Chapter- 12: Appendix: Acronyms
Table 61 : Acronyms Used in This Report
